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PROGRESSIVE VACCINIA COMPLICATING
LYMPHOSARCOMA
Michael F. Dixon, M.B.Ch.B., (Edin.1
PREFACE
The performance of post-mortem examinations is an important
part of the work of a practising pathologist. Many of these
examinations would appear "straightforward" to the casual observer,
but there are few in which a thorough dissection does not reveal
some unexpected finding. Occasionally one is confronted by a
rarity, and the post-mortem examination takes on greater
significance contributing new facts to our understanding of
disease processes. This report describes such a case, an example
of progressive vaccinia complicating lymphosarcoma; one which
stimulated a detailed histological and electron-microscopy study.
Rarity alone, however, is insufficient justification for
such a lengthy analysis. The most interesting aspect of this
case is the gross immunological "breakdown" whereby the patient
succumbed to a fulminant, disseminated infection by vaccinia virus,
a virus which the vast majority of subjects localize to the skin
and rapidly eliminate. That this breakdown occurred in a patient
with lymphosarcoma, and was exaggerated by steroid therapy, has
important implications regarding host defences to virus infection.
It is these implications that make the case worthy of detailed
consideration.
INTRODUCTION
Progressive vaccinia is the rarest and most grave of the
complications of anti-smallpox vaccination. In this disorder
the normal cessation of virus multiplication by the 10th day
after vaccination does not occur and the lesion fails to undergo
regression. The vesicle continues to enlarge and forms a
sloughing ulcer whose advancing edge is associated with large
satellite vesicles. Metastatic lesions appear at distant
cutaneous and visceral sites as a result of blood-borne infection,
and most cases die, Progressive vaccinia must be distinguished
from the more common condition, generalised vaccinia, in which
widespread lesions also occur, but these resolve in a normal
manner and rapid recovery is the rule.
Most cases of progressive vaccinia have occurred in children
and have been associated with lav levels or absence of gamma¬
globulin (Kempe, i960). In adults, however, a striking
association with malignant lymphoreticular neoplasms (reticuloses)
and leukaemias is emerging. This association was present in 36
of the 40 adult cases of progressive vaccinia found in the
literature.
The present case is an example of progressive vaccinia
developing in a patient with lymphosarcoma, an association which
has been recorded in only one previous case (Oberg, Nathorst-
Windahl and Wessldn, 1958). The case is noteworthy in that it
illustrates the exacerbating effects of steroid therapy and
previous irradiation on vaccinial infection. In addition this
patient /
patient developed a severe vaccinial pneumonia, and the presence of
virus in the lungs was confirmed by electron microscopy.
Clinical Summary
The patient, a man aged 67, first presented in 19^3 with a
dislocated shoulder. On clinical examination at that time he was
found to have enlarged axillary and cervical lymph-nodes and
subsequent biopsy of an axillary gland revealed the appearances of
lymphosarcoma.
He was treated with radiotherapy on numerous occasions; the
last course of irradiation, for enlarged mesenteric glands, being
in October 1968. During this period of treatment he developed
mild diarrhoea. He was discharged home at the beginning of
November 1968.
Shortly after discharge he requested vaccination prior to a
trip abroad, and this was carried out by his general practitioner
on 15 Nov. 1968. Four days later he appeared for routine'follow-up
at the Radiotherapy Clinic and haematological investigations
indicated the presence of mild haemolytic anaemia. As no one was
aware that the patient had been vaccinated, a course of prednisolone,
15 nig per day, was recommended, and the steroid therapy commenced
on 27 Nov. 1968 - i.e., 12 days after vaccination.
The patient had previously been vaccinated in infancy and in
1943, and initially developed a mild reaction of immunity. On
1 Dec. however, extension of the inoculation site was noted.
Prednisolone was stopped on 3 Dec. and he was put on prophylactic
Ampicillin to prevent superinfection.
The /
The arm lesion became progressively worse and satellite and
metastatic vesicles appeared. He again developed diarrhoea and
this was attributed to Ampicillin treatment. On 9 Dec. he was
admitted to hospital where, despite treatment with hyperimmune
gamraa-globulin, his condition remained unchanged. Three days
later there was a sudden deterioration, and he complained of
breathlessness, sweating and vague chest pain with radiological
evidence of consolidation in the left basal zone. The clinical
impression was of pulmonary embolism possibly secondary to .axillary
vein thrombosis in the left arm. Despite intensive care he died
later the same day, 27 days after vaccination.
There was no evidence during this final illness of progression
of the lymphosarcoma to lymphatic leukaemia. The maximum white
blood cell count was 9200 per pi with only 15 per cent, lymphocytes.
A blood culture taken on the day of his death produced a
growth of Salmonella typhimurium. Mild diarrhoea had been
present since his last period of hospitalisation, but this
organism had not been isolated from the faeces.
PATHOLOGICAL CHANGES
Necropsy Findings
The post-mortem examination was performed 37 hr after death.
Extensive ulceration was present around the vaccination site
on the left upper arm. The blackened circular ulcer was 6 cm in
diameter and surrounded by a wide zone of blue discoloration.
The remainder of the am and the dorsum of the hand were
oedematous, and numerous satellite lesions studded the skin of the
am. /
arm. Scattered metastatic lesions were present, mainly on the
trunk and the right arm.
On internal examination, enlarged lymph-glands were found in
both axillae, in the mediastinum and throughout the mesentery.
In the cardiovascular system there was no evidence of
pulmonary embolism or of myocardial infarction, and dissection of
the left subclavian and axillary veins failed to reveal in-situ
ante-mortem thrombus.
The lungs were considerably heavier than normal, the left
weighing 980 and the right 1040 g. All lobes were markedly
affected by pulmonary oedema; both lower lobes felt firm and
contained numerous pale areas of consolidation.
The liver (1650 g) and the spleen (350 g) were somewhat
enlarged, but showed no macroscopic abnormality.
Vaccinial lesions were not present in the mucosa of the pharynx,
oesophagus or trachea.
All other systems were of normal appearance. In particular,
the intestines were free of ulceration and there was no apparent
enlargement of lymphoid tissue within the bowel wall. The brain
was not available for examination.
Histology
Lymph-glands, The normal architecture of the glands is
completely destroyed and is replaced by a solid sheet of lymphocytes,
A small proportion of the cells have larger vesicular nuclei and
are recognisable as lymphoblasts. Small aggregations of
lymphocytes are present outside the capsule within surrounding
adipose /
adipose tissue. The appearances are those of lymphosarcoma
(fig. 1).
Skin. Sections of skin taken from the edge of the ulcerated
area reveal marked thickening of the epidermis with conspicuous
vacuolation of epidermal cells and some intra-epidermal
vesiculation (fig. 2). The underlying dermis is oedematous and
haemorrhagic and the capillaries are dilated and congested. A
striking feature is the greatly diminished inflammatory reaction,
represented only by a few scattered lymphocytes in the upper
dermis (fig. 3).
Examination of sections stained with phloxine-tartrazine,
Mann's and Giemsa stains do not reveal unequivocal inclusion
bodies, although moderate numbers of cells contain granular
eosinophilic collections that are presumably cytoplasmic
degenerative material.
Lung. Sections of lung taken from the upper lobes show
widespread involvement by proteinaceous oedema with swelling of
alveolar walls (fig. 4). The alveoli contain histiocytes
presumably shed from the walls. The consolidated areas in the
lower lobes present a more unusual appearance. The alveoli are
largely obliterated by a dense fibrinous oedema, which again is
infiltrated by small numbers of macrophages (fig. 5). Within
this consolidated tissue, large necrotic foci containing scattered
pyknotic and fragmented nuclei are present (figs. 6 and 7).
These areas of consolidation are associated with only a few
scattered polymorphs, although small aggregations of lymphocytes
are present in association with the bronchi.
The /
The bronchial epithelium shows marked hyperplasia, being
increased in thickness and displaying obvious mitotic activity
(figs, 8 and 9). Inclusion bodies are not seen.
G-ram and periodic acid-Schiff stains fail to reveal bacteria
or yeasts in association with the lung lesions.
Liver. The liver contains numerous scattered foci of
necrosis, which consist in the main of a few cells showing
cytoplasmic vacuolation and loss of nuclei, but occasional larger
circumscribed areas of necrosis are present (fig. 10). Increased
numbers of Kupffer cells, many with prominent cytoplasm, are seen.
The portal tracts show heavy infiltration by lymphocytes, and
occasional lymphocytes are present within sinusoids. The areas
of necrosis are not, however, associated with a leucocyte reaction;
they are surrounded by a zone of congestion and, in some instances,
increased numbers of macrophages. Polymorphonuclear leucocytes
and macrophage granulomata are not seen.
Spleen, The spleen is hypocellular and shows complete loss
of the normal architecture. Germinal centres are absent and the
tissue consists largely of markedly congested red pulp. In some
vessels, subendothelial collections of lymphocytes are seen
(fig. 11). Polymorphonuclear leucocytes are absent.
Sections of myocardium, thyroid, adrenals and kidneys showed
no notable abnormality. Fibrin stains were performed on sections
of liver and kidney, but these proved negative.
Electron Microscopy
Electron microscope examination was carried out on specimens
of /
Pig. 1. Lymph-gland. Loss of normal architecture and replacement
by a sheet of lymphocytes, with local infiltration into
the surrounding adipose tissue. Haematoxylin and eosin.
x 75.
Pig. 2. Skin from edge of the ulcer. Epidermis thickened, with
"ballooning" of epithelial cells and intra-epidermal
vesiculation. HE. x 75.
Fig. 3. Skin; epidermal-dermal junction. Edge of ulcer shows
in the upper dermis markedly diminished inflammatory
reaction with small numbers of lymphocytes. HE. x 320.
Fig. 4. Lung, right upper lobe. Alveoli filled with
proteinaceous exudate containing macrophages.
HE. x 95.
Pig. 5. Lung, lower lobe. Both lower lobes show widespread
sero-fibrinous oedema infiltrated by scanty macrophages
and lymphocytes. HE. x 95.
Pig. 6. Lung, lovfer lobe. Necrotic focus containing conspicuous
strands of fibrin, macrophages and numerous pyknotic and
fragmented nuclei. HE., x 95.
Pig. 7. Lung. Necrotic area with coarse meshwork of fibrin,
granular degenerate cells devoid of nuclei, macrophages,
and nuclear debris. HE. x 320.
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Bronchial epithelium. Stratification of epithelium and
a mitotic figure. HE. x 425.
Small splenic vessel vdth dense surrounding cuff and sub-
finrlothfjj^j n nil pp. t.i on m£_] "h nn ,rf^ o tro „_oe
of skin and lung.
The tissue had initially been fixed in corrosive formol
solution for routine histological examination and had therefore
to be specially processed prior to electron microscopy.
The tissues were cut into small pieces each about 1 cu.mm.
in size. These were immersed in 1% iodine solution for 2 hours
to remove mercury pigment. After 1 hour in 5% sodium thiosulphate
solution the pieces were washed in distilled water.
The material was then "post-fixed" in 1% osmium tetroxide,
buffered with veronal acetate, for 2 hours. Dehydration followed,
and was performed according to this schedule:-
3 changes each of 15 mins. in 10% ethanol,
1 period of 15 mins, in 50% ethanol,
3 changes each of 30 mins. in absolute ethanol,
finally, 2 changes each of 20 mins. in 1:2 epoxypropane.
The fixed and dehydrated tissue was next impregnated with
"ARALDITE". After leaving overnight at room temperature in
polythene "boats"; the impregnated tissue was incubated at 56°G
for 30 minutes to evaporate any residual epoxypropane. Embedding
in fresh ARALDITE followed, and incubation at 56°C for a further
48 hours.
Sections were cut on a LKB Automatic Ultramicrotome, and
collected on ATHENE type 483 E.M, grids. Suitable sections
were stained with Reynold's lead citrate (2 mins) and saturated
uranyl acetate in 50% ethanol (15 mins).
The grids were examined on an A.E.I. E.M.6 electron microscope
and representative micrographs taken.
Electron Microscopy Findings /
 
Pig.13. Skin. Higher power showing virion with biconcave
nucleoid. EM. x 60,000.
Pig.14. Skin. Two immature virions showing granular viroplasm
and double-membrane. EM. x 100,000.
Fig.15. Lung. The field contains numerous virions at various
stages of maturation. EM. x 32,000.
Eig.16. Vaccinia virus within lung tissue. These are largely
mature types. The large granular area is part of a
red blood cell. EM. x 20,000.
Eig.17. Higher power view of an individual virion showing the
characteristic biconcave nucleoid, granular viroplasm,
and double membrane. EM. x 100,000.
Electron Microscopy findings
In both skin and lung sections large numbers of vaccinia
virus were identified. The individual virions vary from 21+1+ to
305 nm in diameter, and various morphological forms are present
(figs, 12 - 15 ). The majority are spherical with granular
viroplasm enclosed in a double membrane, whilst a smaller number
contain a biconcave nucleoid separated from the granular material
by a zone of lesser density (figs. 16 and 17),
DISCUSSION
Review of the Literature
The last review of the literature was published in 1 961 by
Erichson and McNamara, They found twelve cases of progressive
vaccinia in the English literature, of which three were in adults.
Davidson and Hayhoe (19^2) cited ten authors who had reported
progressive vaccinia accompanying reticuloses and leukaemias.
The present survey has revealed forty adult cases in the world
literature. They are detailed in the accompanying table and
are arranged in relation to the underlying disease.
Ramond, Jacquelin and Borrien (1922) described three patients
with malignant lympho-reticular neoplasms in whom vaccination
provoked a marked deterioration in their general condition, which
in two cases led to death. In these cases, however, the
vaccination site, after an initial severe reaction, resolved
normally. They ascribed the deleterious effect of vaccination
to "a symbiosis between the vaccinia virus and the virus causing
the lymphoid neoplasm",
Of further interest is the case reported by Waddington et al.
(1964) /
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Severalsm llin¬ farctswi hmulti¬ focalalveolar haemorrhages
(1964) of progressive vaccinia in a boy of thirteen with acute
leukaemia, who had received large doses of steroids, methotrexate
and 6-mercaptopurine prior to vaccination.
Histology and electron-microscope findings
The majority of reports of progressive vaccinia have been
clinically orientated and contain little detailed description of
post-mortem findings. A comprehensive pathological description
is included in a case of progressive vaccinia in a child of 6 mth
reported by Hall, Cunliffe and Dudgeon (1953) and their findings
parallel closely those observed in the present case. In the
cutaneous lesions, for example, they found a complete absence of
inflammatory cells. Whilst small numbers of lymphocytes were
found in the present case, it appears that absence of
polymorphonuclear leucocytes, and a diminished or absent
ljmiphocytic response, are constant features of progressive
vaccinia.
The inclusion bodies of vaccinia have been fully described
by Kamahora et al. (1958) and Kato et al. (1959). They
demonstrated that the Guarnieri body of vaccinia is an intra-
cytoplasmic "B"-type inclusion; that is, it is irregular in
shape, haematoxylinophilic, and stains reddish-purple with Giemsa
stain. The finding of round circumscribed eosinophilic inclusions
("A" type) is rare in vaccinia, and then occurs only if the strain
is of cowpox, as opposed to variola, origin.
Although inclusion bodies were not found in this case or in
the case of Hall et al., their absence is not a constant feature
of /
of progressive vaccinia, as they are stated to have been found
in the skin of a child reported by Bigler and Slotkowski (1951).
A further point of similarity between the present case and
that of Hall et al. is the finding of foci of necrosis within the
liver. These foci, which are unusual in that they lack an
associated inflammatory cell response, have also been described
in human vaccinial infection by Dible and G-leave (1934), and in
experimental vaccinia in rabbits by Lillie and Armstrong (1930).
Although foci of necrosis are found in the liver in salmonellosis,
they are usually associated with macrophage granuloinata, which
were not present in this case.
The histology of the spleen is difficult to evaluate and
appears to have been modified by a prolonged stress reaction and
steroid therapy. Some features are suggestive of an endotoxaemia,
but the absence of polymorphonuclear leucocytes in the spleen, and
of fibrin in the renal glomerular capillaries, do not support this
diagnosis. Thus, the histological findings indicate that the
terminal Salmonella typhimurium bacteriaemia was of limited
pathological significance.
The most interesting features of the present case are the
widespread and severe lung changes. Whilst lung lesions were
present in five of the adult cases of progressive vaccinia, a
detailed microscopic description of these lesions is not included
in any of the reports. In only one case, that reported by Oberg,
Nathorst-Windahl and Wessldn (1958), was virus isolated from the
lung and this was from "probably aspirated material". The
presence of extensive serofibrinous oedema and a scanty
macrophagic /
macrophagic response are appearances similar to those found in the
human infection by Hall et al., and in experimental vaccinia in
rabbits by Lillie and Armstrong. Hyperplasia of the bronchial
epithelium has not previously been observed in human vaccinial
infection, but has been seen in the rabbit (Montasir, Rabin and
Phillips, 1966).
The histological appearances were suggestive of a vaccinial
pneumonia, and electron microscopy confirmed the presence of virus
particles. Lung sections revealed large numbers of virions, and
a variety of morphological forms were observed similar to those
found in experimental vaccinial pneumonia in mice by Montasir et
al. The various morphological forms are related to the sequence
of maturation as described in the chick chorio-allantois by
Gaylord and Melnick (1953) and Morgan et al. (1954). Large
numbers of virus particles were also identified in the sections
of skin. This is the first case of progressive vaccinia in
which vaccinia virus has been demonstrated in post-mortem material
by means of electron microscopy.
Immunological aspects
Defective antibody formation is a well-established feature of
both the reticuloses (Evans, 1948; Silver et al., 1958; Barr and
Fairley, 1961) and leukaemias (Howell, 1920; Shaw, i960). The
association of progressive vaccinia with such disorders, and its
increased frequency in children with agammaglobulinaemia (Kempe,
1960) led a number of authors to conclude that a failure in
formation of neutralising antibodies was a sine qua non for the
development of this complication. For example, a typical
definition of progressive vaccinia describes it as "An extremely
rare complication of smallpox vaccination ... characterised by a
complete inability to make specific antibodies against the vaccinia
virus" (Kempe and Benenson, 1955).
Four cases have been reported, however, where progressive
vaccinia has occurred despite the presence of adequate levels of
circulating neutralising antibodies, three in adults (Daly and
Jackson, 1962; Davidson and Hayhoe, 1962; O'Connell et al., 1964),
and one in a child (Hansson, Johannson and Vahlquist, 1966). It
therefore appears that a normal gamma-globulin level is no
guarantee against the occurrence of progressive vaccinia. In
addition, patients with agammaglobulinaemia often have a normal
primary response to vaccination and develop an immune response on
repeat vaccination despite the absence of detectable serum anti¬
bodies (Apt, 1953).
Further evidence against a major role for antibody in primary
vaccinial infection is provided by animal experiments. Irradiated
guinea-pigs /
guinea-pigs in which no neutralising antibody could be demonstrated
recovered from vaccinia virus infection as rapidly as did normal
animals; the irradiated guinea-pigs did, however, develop delayed
hypersensitivity to vaccinia during recovery (Friedman and Baron,
1961). Similarly, chick embryos may recover from a variety of
viral infections, including vaccinia, although they are unable to
produce antibodies (Baron and Isaacs, 1961).
These findings have prompted suggestions that delayed
hypersensitivity may be more important than antibody in recovery
from vaccinial infection (Dienes and Naterman, 1936; Kempe).
Clinical support for this view is provided by the cases of
O'Connell et al. and Hansson et al., where, although the patients
had an adequate titre of neutralising antibody, scratch tests with
inactivated virus failed to produce a delayed skin reaction.
O'Connell et al. postulated a causal relationship between failure
of the cellular immune response and the development of progressive
vaccinia. Kempe reported a case in which the injection into the
edge of the necrotic skin lesion of leucocytes and lymph-gland
material from immune donors produced a dramatic improvement, and
O'Connell et al. attributed the benefit of blood transfusion in
their patient to the transfer of immune leucocytes. The ability
of immunologically competent cells to alter the course of the
disease confirms the importance of cellular immunity in recovery
from vaccinial infection.
The results of experimental work on cellular responses have
been contradictory. Turk, Allison and Oxman (1962) produced
delayed /
delayed hypersensitivity in guinea-pigs in the absence of
demonstrable antibody, and showed that there was little difference
in the quantity of virus that multiplied in these animals as
compared with normal animals. Similarly, Friedman et al. (1962)
showed that guinea-pigs in which antibody production and delayed
hypersensitivity were blocked recovered as well as normal animals
did. These authors concluded that cellular immunity is not a
major factor in recovery from primary vaccinial infection. Flick
and Pincus (1963), Pincus and Flick (19&3) and Pincus, Flick and
Ingalls (1963) differ sharply from Friedman et al., for they-
reported a series of experiments that clearly demonstrated the
importance of cellular immunity. They found that the ability of
various inbred strains of rabbits to develop rapid and severe
reactions to vaccinia was directly proportional to their ability
to mount delayed hypersensitivity to other antigens. They also
demonstrated that techniques that inhibited the expression of
cellular immunity, e.g., inoculation of "antimononuclear-cell"
serum locally or the induction of neonatal immunological
unresponsiveness, inhibited the primary vaccinia lesion. Hirsch
et al. (1968) administered rabbit anti-mouse-thymocyte serum to
mice to suppress host cell-mediated responsiveness to intravenously
administered vaccinia virus, and found increased morbidity and
mortality in the treated animals. There was no parallel effect
on either antibody or interferon production in response to vaccinia
virus in these mice.
On balance thedinical and experimental evidence suggests that
cellular /
cellular immunity is an important factor determining recovery from
primary vaccinial infection. The depression of delayed hyper¬
sensitivity observed in patients with reticuloses (Rostenberg and
Bluefarb, 1954; Epstein, 1958; Pairley and Matthias, 1960;
Aisenberg, 1966) therefore offers one explanation for the consistent
association between these diseases and the development of progressive
vaccinia. This depression of delayed hypersensitivity is possibly
due to failure of the neoplastic lymphoid cell to function as an
effector of cellular immunity. Pairley (19&9) suggests, however,
that in cases of Hodgkin's disease most lymphocytes may be committed
to react against the neoplastic tissue and are therefore unable to
react against other antigens, and that this explains the gross
impairment of cellular immunity in these patients.
Cellular immunity, however, is not the only factor determining
recovery from viral infections, and there is increasing evidence
that non-immune mechanisms play a fundamental part. The most
important of these is interferon production.
The protective effect of interferon against vaccinial infection
has been demonstrated both by intradermal administration (Isaacs and
Westwood, 1959; Andrews, 1961) and by stimulation of endogenous
systemic interferon production (Petralli, Merigan and Wilbur, 1965).
That interferon production is defective in progressive vaccinia is
indicated by a recent case in which the interferon-producing
capacity of leucocytes was found to be markedly depressed (van Rooyen
et al», 1967). Whilst such findings suggest that administration of
interferon to these patients would be beneficial, use of exogenous
interferon in a child with progressive vaccinia failed to influence
the /
the progress of the disease (Conolly, Dick and Field, 1962).
However, only a low final serum titre of interferon was achieved in
this case.
Defective production of interferon might be the most important
factor in the development of progressive vaccinia. How then is
defective production linked with the reticuloses and myeloproli¬
ferative disorders?
Interferon production is initiated by the action on cellular
metabolism of an "inducer". This inducer has been identified as
the nucleoprotein component of the virus (Burke et al., 1968).
Though all cells are capable of interferon synthesis, the
finding that the reticulo-endothelial system is the main source
of systemically induced interferon is of considerable interest
(Kono and Ho, 1965). It is thought that macrophages trap and
concentrate the inducer and make it available to the interferon
producing cells (Ho, Postik and Ke, 1968), a mechanism analogous
to the trapping of antigens in antibody-forming organs to facilitate
the production of antibody. Just as depression of phagocytic
activity leads to a reduction of antibody production (Stuart and
Davidson, "\SGk-) diminished phagocytosis by macrophages results in
deficient interferon production (Kono and Ho).
The status of phagocytic activity in the reticuloses is in
some doubt. G-roch, Perillie and Finch (19&5) found depressed
phagocytic activity in patients with leukaemia, lymphoma and
multiple myeloma, whilst others have demonstrated a hyper-phagocytic
state in similar cases (Salky et al., 19&7; Sheagren, Block and
Wolff, 1967). These discrepancies may result from difficulty in
assessing /
assessing the stage of the disease, for in mouse leukaemia enhanced
phagocytosis is seen in the early stages of the disease, but as the
involvement progresses phagocytic activity diminishes (Old et al.,
1960).
Deficient production of systemic interferon, even in the
presence of normal or increased phagocytosis, might ultimately be
due to a failure of neoplastic cells to respond to the inducer.
This hypothesis is supported by the finding that leucocytes from
patients with leukaemia and lymphoma exhibit reduced interferon
production as compared with normal leucocytes after in-vitro"
stimulation by virus (Hayashi, Sharpies and Lo G-rippo, 1966;
Lee. Ozere and van Rooyen. 1966). With the recent development
of precise methods for interferon quantitation (Pinter, 1966) a
study of systemic interferon production in patients with reticuloses
and leukaemias would be of considerable interest.
Thus far, only the impairment of immune responses brought
about by the underlying disease has been discussed. A further
important consideration is the effect on immune reactivity of
corticosteroids, antimetabolite chemotherapy and irradiation, for
at least ten of the reported cases had received such treatment.
The enhancing effect of corticosteroids on experimental
vaccinial infection has been clearly demonstrated (Rose et al.,
1952; Bugbee, Like and Stewart, i960). Corticosteroids have
been shown to depress antibody formation (Bjp'rneboe, Pischel and
Stoerk, 1951) and to cause lymphopenia and involution of lymphoid
tissue (Dougherty, 1953). Of more importance is the finding that
cortisone administration markedly depressed the interferon response
in /
in experimental animals (Burke, 1966; Rytel and Kilbourne, 1966;
Lavelle and Starr, 1968). Whilst this effect may be due to direct
suppression of interferon production, the striking depression of
phagocytic activity brought about by corticosteroids (Heller, 1955;
Nicol, Snell and Bilbey, 1956; Nicol and Bilbey, 1958) indicates
that a failure to trap and concentrate viral inducer might be the
predominant factor involved.
Antimetabolites have similarly been shown to impair immune
responses. Depression of antibody production (Condie, Mennis
and Miller, 1961) inhibition of lymphocyte response (Page, C'ondie
and G-ood, 1962; Page, 1964) and reduced phagocytic activity
(Megirian, Walton and Lang, 1959; Megirian, 1965), have been
demonstrated by the use of a variety of antimetabolic drvgs.
Although irradiation leads to diminished antibody production
and lymphopenia (Wilson and Miles, 1946), its effects on interferon
production are variable, and at therapeutic levels probably has
little influence. Hellman, Martin and Wopschall (1968) found no
significant alteration in interferon levels in irradiated animals.
Thus, the state of altered immunity predisposing to the
development of progressive vaccinia includes both a deficient
cellular response and depressed interferon production. These
changes are largely attributable to the underlying lymphoreticular
or myeloproliferative disease, but the additional impairment
resulting from the administration of corticosteroids, anti¬
metabolite drugs, and possibly from irradiation constitutes an
important factor in the pathogenesis of this rare complication.
The potentially fatal complications of vaccination could be
avoided /
avoided by using an inactivated vaccine. Unfortunately the
development of an effective heat-killed vaccine has met with only
partial success (Madely, 1968). Until such a vaccine is available,
patients suffering from a reticulosis or leukaemia, under treatment
with immunosuppressive drugs, or undergoing irradiation, should be
warned of the dangers of anti-smallpox vaccination.
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